Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Future Med Chem ; 11(7): 693-705, 2019 04.
Article in English | MEDLINE | ID: mdl-30964329

ABSTRACT

Targeted liposomes with different combinations of five ligands (for brain/amyloid targeting) were evaluated for hemocompatibility. Results reveal that all liposomes studied, caused minimum hemolysis; targeted liposomes slightly reduced blood coagulation time, but not significantly more than control liposomes; and compliment factors SC5b9 and iC3b increased when compared with the buffer, by most targeted liposomes. However, the specific amounts of both factors were similar with those induced by control liposomes. Thus, the targeted liposomes are unanticipated to cause hypersensitivity problems. Good correlations between vesicle size and produced factor amounts were observed. In conclusion, the current targeted liposomes are not expected to cause serious blood toxicity, if used in vivo.


Subject(s)
Amyloid/metabolism , Biocompatible Materials/chemistry , Biocompatible Materials/metabolism , Liposomes/chemistry , Liposomes/metabolism , Antibodies, Monoclonal/metabolism , Apolipoproteins E/chemistry , Blood Coagulation/drug effects , Brain/metabolism , Complement C3b/metabolism , Complement Membrane Attack Complex/metabolism , Curcumin/chemistry , Ethanolamines/chemistry , Hemolysis/drug effects , Humans , Nanoparticles/chemistry , Particle Size , Phosphatidylcholines/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...